Skip to main content

Part of the book series: Key Topics in Brain Research ((KEYTOPICS))

  • 141 Accesses

Summary

Muscarinic full and partial agonists were compared in rats for induction of hippocampal EEG effects (RSA) and falls in blood pressure and heart rate. Full agonists induced strong RSA and strong, higher potency, cardiovascular (CVS) effects. Partial agonists induced weak RSA and weaker, lower potency, CVS effects. RSA involves the septo-hippocampal cholinergic system which degenerates in dementia. It is inferred that partial agonists will cause weaker anti-dementia effects but less undesirable side effects than full agonists.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Bevan P (1984) Effect of muscarinic agents on the electrical activity recordedfrom the hippocampus: a quantitative approach. Br J Pharmacol 82: 431–440

    Article  PubMed  CAS  Google Scholar 

  • Bland BH (1986) The physiology and pharmacology of hippocampal formation theta rhythms. Prog Neurobiol 26: 1–54

    Article  PubMed  CAS  Google Scholar 

  • Brown F, Clark M, Graves D, Hadley M, Hatcher J, McArthur R, Riley G, Semple J (1988) Variation of muscarinic activities of oxotremorine analogues. Drug Dev Res 14: 343–347

    Article  Google Scholar 

  • Clark MSG, Hatcher J, Brown F (1989) Relative aversive potency of muscarinic agonists. TIPS [Suppl 4]: 100

    Google Scholar 

  • Wettstein A, Spiegel R (1984) Clinical trials with the cholinergic drug RS 86 in Alzheimer’s disease (AD) and senile dementia of the Alzheimer type (SDAT). Psychopharmacology 84: 572–573

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Wien

About this chapter

Cite this chapter

Loudon, J., Brown, F., Clark, M., Riley, G. (1990). Hippocampal and cardiovascular effects of muscarinic agents. In: Maurer, K., Riederer, P., Beckmann, H. (eds) Alzheimer’s Disease. Epidemiology, Neuropathology, Neurochemistry, and Clinics. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3396-5_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-3396-5_23

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-82197-8

  • Online ISBN: 978-3-7091-3396-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics